Successfully reported this slideshow.

India's leading pharmaceutical company 2021

0

Share

1 of 28
1 of 28

India's leading pharmaceutical company 2021

0

Share

Download to read offline

Insights Success’ latest issue, India's Leading Pharmaceutical Company - 2021, in order to highlight one of the renowned companies – ‘Century Pharmaceuticals Limited,’ that is changing the face of the pharmaceutical industry.

Insights Success’ latest issue, India's Leading Pharmaceutical Company - 2021, in order to highlight one of the renowned companies – ‘Century Pharmaceuticals Limited,’ that is changing the face of the pharmaceutical industry.

More Related Content

Related Books

Free with a 14 day trial from Scribd

See all

Related Audiobooks

Free with a 14 day trial from Scribd

See all

India's leading pharmaceutical company 2021

  1. 1. Pharma Insights Dynamics of Pharmaceutical Companies in the Covid-19 Pandemic: Current Global Industry Scenario Vol. 07 | Issue 02 | 2021 CENTURY PHARMACEUTICALS LIMITED A Leading Pharmaceutical Company in the World Today India's Leading Pharmaceutical company 2021 Janak Sheth Managing Director
  2. 2. he pharmaceutical industry of India is Tone of the most prominent global producers of cost-effective generic medicines and vaccines. It plays an important part by supplying for 20% of the total global demand by volume and 62% of the global demand for vaccines. It is expected that the country will efficiently fulfil the global demand for covid-19 vaccines, especially in the low- income and middle-income countries. In terms of pharmaceutical production by volume and by value, India bags the third and fourteenth ranks, respectively. The domestic pharmaceutical industry of the country is sturdy, as it has a strong network of 3,000 drug companies and around 10,500 manufacturing units. Out of these, more than 2000 units are approved by the World Health Organization (WHO) good manufacturing practice (gmp); 253 are approved by the European Directorate of Quality Medicines (EDQM); 1,105 have received Europe’s Certificate of Suitability (CEPs); more than 950 match therapeutic goods administration (TGA) guidelines; and the US Food and Drug Administration (US FDA) have approved 584 sites. The pharmaceutical industry of India is renowned for producing a wide range of drugs in bulk amount. These drugs act as key ingredients with medicinal properties that form the basic raw materials for formulations. The leading pharmaceutical companies of India put in their best efforts and engage deeply in research, development, and distribution of drugs and medication. These companies focus on producing life-saving drugs and medical treatments, while ensuring that the patients are relieved of all their physical ailments. Accordingly, they spend a lot of time and resources to develop new technologies, build infrastructures, and extensively carry out tests to make sure that the medications that they are producing are safe to use and effective at the same time. Without these top companies producing essential medicines, it is difficult to imagine treatments for common diseases and also the lethal ones. These pharmaceutical companies abide by the rules and regulations established by various international regulatory bodies. These bodies may monitor things such as the prices charged by drug companies, the quality of the drug and the manufacturing process, the safety of the drug and the possible side effects, and so on. The prominent names in the pharmaceutical industry leave no stone unturned to provide people with safe and efficient drugs which would help them to receive a cure for different diseases. They are working hard day and night to come up with more efficient and effective medicines and solutions. Hence, in order to highlight one of the renowned companies – ‘Century Pharmaceuticals Limited,’ that is changing the face of the pharmaceutical industry with its dedicated endeavours, we present to you Insights Success’ latest issue, India's Leading Pharmaceutical Company - 2021. Browse through to know the latest updates of the company and more. Read Away! Exploring the Pioneers of Pharmaceuticals and Healthcare From the EDITOR Ananda Kamal Das ananda@insightssuccess.com
  3. 3. recognizes Sumita Sarkar Editor-in-Chief It is transforming the Indian pharmaceutical sector dynamically with its prompt services and solutions for the clientele. 2021 India's Leading Pharmaceutical company 2021 as Century Pharmaceuticals Limited
  4. 4. Copyright © 2021 Insights Success Media and Technology Pvt. Ltd., All rights reserved. The content and images used in this magazine should not be reproduced or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights Success Media and Technology Pvt. Ltd. Reprint rights remain solely with Insights Success. Printed and Published by Insights Success Media and Technology Pvt. Ltd. Follow us on : www.facebook.com/insightssuccess/ https://twitter.com/insightssuccess Cover Price : RS. 150/- RNI NUMBER: MAHENG/2018/75953 Editor-in-Chief Sumita Sarkar Deputy Editor Abhishaj Sajeev Managing Editor Darshan Parmar Assisting Editor Ananda Kamal Das Contributing Writer Ashish Chandgude Chief Designer Asha Bange Designing Head Priyanka Rajage Co-designers Vishal , Rashmi Operations Head Megha Mishra Business Development Manager Ashwini Pahurkar Business Development Lead Tejswini Whaval Business Development Executive Sneha Nagare Technical Head Aditya Kothare Technical Specialist Amar Sawant Digital Marketing Manager Amol Wadekar SME-SMO Executive Atul Dhoran Circulation Manager Tanaji Insights Success Media Tech LLC 555 Metro Place North, Suite 100, Dublin, OH 43017, United States Phone - (614)-602-1754 Email: info@insightssuccess.com For Subscription: www.insightssuccess.com Insights Success Media and Technology Pvt. Ltd. Off. No. 22 & 510, Rainbow Plaza, Shivar Chowk, Pimple Saudagar, Pune, Maharashtra 411017 Phone - India: +91 7410079881/ 82/ 83/ 84/ 85 Email: info@insightssuccess.in For Subscription: www.insightssuccess.in Corporate Offices: sales@insightssuccess.com JULY, 2021 We are also available on
  5. 5. Subscribe Today CORPORATE OFFICE Insights Success Media and Technology Pvt. Ltd. Off No. 22 & 510, Rainbow Plaza, Shivar Chowk, Pimple Saudagar, Pune, Maharashtra 411017. Phone - India: 020- 7410079881/ 82/ 83/ 84/ 85 USA: 302-319-9947 Email: info@insightssuccess.in For Subscription : www.insightssuccess.in Cheque should be drawn in favour of : INSIGHTS SUCCESS MEDIA AND TECH PVT. LTD. Stay in touch. Subscribe to Insightssuccess Get Insightssuccess Magazine in print, & digital on www.insightssuccess.in www.insightssuccess.in
  6. 6. Janak Sheth Managing Director India's Leading Pharmaceutical company 2021
  7. 7. CENTURY PHARMACEUTICALS LIMITED A Leading Pharmaceutical Company in the World Today I THAT BELIEVE WITH HARD WORK AND , DEDICATION WE CAN ANY ACHIEVE GOAL AS LONG AS WE DO NOT OF LOSE SIGHT OUR GOAL “ COVER STORY
  8. 8. To develop, manufacture, and market APIs, Veterinary, and innovative biotech products with new therapeutic products and provide a new direction to the pharmaceutical industry, Century Pharmaceuticals Limited was born. “We hope to create value for all our customers, partners, while complying with government regulatory requirements and applying environmentally safe and socially responsible business practices,” says Janak Sheth, the Managing Director of the company. The company's vision is to be a leader in the industry on the range of products manufactured by its dynamic team as a reliable and dependable source. Century Pharmaceuticals Limited was started in 1980 in the backward district of Panchmahals. With no business experience and limited finance in the family, there were several challenges. However, with a zeal to overcome challenges, the company moved step by step and started producing and selling small quantities of products with a sharp eye on quality. This helped the company to develop two key customers and slowly expanded the business to other companies in time. “Later we went on adding new products and today we have 40 products under manufacturing with us and exporting to more than 60 countries around the world,” says the team at Century Pharma. Industry Dynamics by Janak The scenario in Indian Pharmaceutical space is very opportune. Several companies have grown in India and expanded their operations to other countries. The demand in India is very high and this gives us an economics of scale. Century Pharma have been heavily dependent on Chinese supply
  9. 9. of raw materials. With the PLI scheme of the government, several companies have decided to put large scale plants with government support to help increase the scale and production of key starting raw materials and active ingredients. There is a huge opportunity to cater to Indian market as well as overseas. Most countries find the company's products to be cost effective and of good quality. There is a need to boost further production and market them to third world countries with a win-win approach. Owing to the pandemic there was a huge demand of vaccines. India is one of the largest suppliers of vaccines. Several countries around the world are dependent on supplies from India owing to its lower costs and also large volume of production. “I believe that there is a likelihood of demand coming up for other vaccines as well in time to come like we had for SARS, EBOLA and now COVID,” conveys Janak. Such epidemics might continue and hence the company's ability to supply vaccines in a short time might come in handy. There is a lot of new drug development also taking place. Biotechnology offers a good replacement to chemical products with high side effects. Janak believes that several new products will be introduced which have few or no side effects by working on the concept of targeted therapies. Several multinational companies are doing their research in India being cost effective. Therefore, there is a huge opportunity in pharmaceutical industry. Centuries Ahead “When the industry was set up, there were challenges of finance as we were set up with very limited resources. We started manufacture of 2 products and realized that we were dependent on I BELIEVE THAT TIME IS MONEY AND HENCE, WE WORK TOWARDS IMPROVING THE EFFICIENCY OF OUR SYSTEMS BY TRAINING THE PEOPLE WITH TIME “
  10. 10. THE COMPANY HAS , YOUNG MIDDLE AGED AND SENIOR PEOPLE IN THE ORGANIZATION BUT OF THEM ALL ARE EQUALLY . VIBRANT WE ACCEPT CHALLENGES AND ENJOY OVERCOMING THEM SUCCESSFULLY “
  11. 11. Janak Sheth is the Managing Director of Century Pharmaceuticals Limited. He is also the first-generation entrepreneur in the company. Armed with a Chemical Engineering degree from IIT Delhi, he started his career with Sarabhai Chemicals and in a short time was posted as a Project Engineer for setting up a first pharmaceutical active ingredient plant in Indonesia. Starting with project planning to design of the equipment to be purchased, purchasing the equipment, installing them and later running the plant was an all-round experience with the project. Let's hear his story in his own words: After 4 years with them I left the company and started my own venture with limited finance. The government schemes were very favorable for such startups at that time and my educational career and industry experience helped me get extra ordinary support from financial institutions and Banks to kick start the project. This was possible because of Government capital investment subsidy and seed capital loans to cover up for the shortfall in equity available with me. Initially it was a one man show and as the company grew more people joined the team and started expanding the operations more systematically and professionally. After 35 years in the business, I was honored with a doctorate in Management by KEISIE International University in South Korea. In addition to working in the company, I like to contribute to the industry by participating in industry association programmes to design better policies and working towards ease of doing business in industry. I am also engaged in various social organizations to help the needy.
  12. 12. produced and supplied a lot of this antibiotic. Looking to the pandemic, our research people worked hard to develop an antiviral product Molnupiravir which is very effective in controlling COVID,” informs Janak. Century Pharma's team were happy that the government granted permission to manufacture and supply this new drug to pharmaceutical companies. “We hope that this Molnupiravir drug will be very useful in treating patients suffering from COVID. Owing to COVID several people were suffering from Black Fungus and are dying too,” adds the team of Century Pharma. The company had stopped manufacturing of Amphotericin B, a drug specific for the black fungus. Based on popular demand, its team sourced the raw materials and started to manufacture and supply it to companies manufacturing Amphotericin B soon. Its team hopes this will help alleviate the grave situation the whole world is facing in controlling black fungus. In view of the huge shortage of and this strong bondage helps keep its employees together. “We try to organize picnics and outings to help strengthen the bonds in addition to hosting lunch on any happy occasion in the company,” shares Janak. As a result, the unskilled labor who joined the company during the inception of the company are still working with the company even after 35 years. The story amongst the chemists and managers is no different. “We appreciate loyalty and commitment to growth and in turn the company looks after them,” informs Janak. Navigating through the Pandemic During the first wave, there was a serious shortage of masks and PPE kits in hospitals. The company donated masks and PPE kits to leading COVID hospitals for the frontline workers. Century Pharmaceuticals Limited is engaged in the manufacturing of Azithromycin. Many doctors use Azithromycin to help patients suffering from COVID owing to upper respiratory tract infections. “We only 2 customers for our business,” states Janak. At this point, the company made a conscious effort to get business from new customers. With this initiative it got proposals of new products and slowly expanded not only with existing customers but also new customers. Thereafter, Century Pharma entered in exports with Indonesia and slowly expanded to 60 countries around the world. The challenges faced by the company were overcome by its team with ease and they were always ready for the next challenge. In the last decade the company have been working on the development of new molecules for the treatment and cure for Asthma and allergies with a targeted therapy technology. “We have yet to realize success in this area,” shares the Century Pharma's team. Century Pharmaceuticals Limited believes in continuity and hence has encouraged loyalty amongst its employees. It has developed a culture of a strong family within its employees THE HAS A COMPANY POLICY TO OF ALL BEFORE DISPOSE WORK WE OFFICE SO THAT THE , LEAVE NEXT DAY WE CAN NEWER , FACE CHALLENGES AND THIS HAS OUR HELPED EMPLOYEES TO TO OFF ALL LEARN DISPOSE DAILY WORK ON THE SAME DAY “ Rishabh
  13. 13. ambulances, the company quickly donated its new staff car to be converted into an ambulance to the local hospital. Guiding the Young Ones Indians are good innovators and hence we see a lot of startups in India. With the economy providing increased funding options to these startups, Janak hopes that we can create many unicorns from India. “Our young people have great ideas and most of these ideas are worth to be pursued. Young people can take more risks and help grow themselves and help our country reach the US $ 5 trillion economy target sooner,” advises Janak. He has personally observed that several plants around the world are manned by Indian pharmacists, chemists, and engineers. “I would therefore encourage young people to think of innovation and enterprise and build their careers in pharma industry,” tells Janak.
  14. 14. Pharmaceutical of the tomorrow The company has a wide range of customers, from small, medium, and large including multinational companies. Its team have had great experiences with them and as they have tried to meet the customer requirements, Century Pharma have enjoyed customer loyalty in spite of the fierce competition. With increasing product range, it has become easy for the company's team to cross sell its product with such customers. In view of the pandemic, its team is considering increasing their production capacity. The company have also been working towards personalized cancer treatment with the help of targeted therapy concept. “If we succeed, it would be a huge upside for our company,” says Janak. “India is considered as the pharmacy of the world today, wherein we supply about 25% of the world's medicine and yet there is a lot of room for us to grow as our medicines are the not only cost effective but also of good quality,” claims Janak. Century Pharmaceuticals is Known For • ACENOCOUMAROL • AMLODIPINE BESYLATE • AMPHOTERICIN B INJECTION GRADE • AVANAFIL • AZITHROMYCIN DIHYDRATE • CHLORAMPHENICOL • CHLORAMPHENICOL PALMITATE • CLARITHROMYCIN • DAPOXETINE HCL IHS • EMPAGLIFLOZIN • ERYTHROMYCIN • ERYTHROMYCIN ESTOLATE • ERYTHROMYCIN ETHYL SUCCINATE • ERYTHROMYCIN PHOSPHATE • ERYTHROMYCIN STEARATE • FLIBENSARIN • FLUTICASONE PROPIONATE • GRAMICIDIN • LEDIPASVIR • LINAGLIPTIN • MOLNUPIRAVIR * NEW DRUG • OXYTETRACYCLINE • (BASE DIHYDRATE – SUITABLE FOR INJ PREPARATION) • OXYTETRACYCLINE HCL (INJ GRADE) • PALONOSETRON HCL • PHENYL BUTAZONE • ROSUVASTATIN CALCIUM • ROXITHROMYCIN • SEVELAMER CARBONATE 845273-93-0 • SEVELAMER HYDROCHLORIDE 152751-57-0 • SILDENAFIL CITRATE • SOFOSBUVIR • TADALAFIL • TETRACYCLINE HCL • TIAPRIDE • VARDENAFIL HCL TRIHYDRATE • VILDAGLIPTIN • Vit D derivatives • CALCITRIOL - 32222-06-3 • ALFACALCIDOL - 41294-56-8 • CALCIPOTRIOL - 112965-21-6 • Anti-glaucoma • BIMATOPROST – 155206-00-1 • CARBOPROST - 58551-69-2 • LATANOPROST - 130209-82-4 • MISOPROSTOL - 59122-46-2 • TAFLUPROST - 209860-87-7 • TRAVOPROST - 157283-68-6 • Ophthalmic • DORZOLAMIDE HCL - 120279-96-1 • BRINZOLAMIDE - 138890-62-7
  15. 15. Pharma Insights 20 | JULY 2021 | www.insightssuccess.in
  16. 16. The COVID-19 pandemic had a wide range of effects on the pharmaceutical industry, including delaying routine therapies, putting a strain on healthcare budgets, delaying drug production for diseases other than COVID and disrupting supply chains. To meet the challenges faced by the pandemic, the pharmaceutical industry was forced to embrace a variety of digital technologies. Technologies like cloud computing and cybersecurity have aided the industry in adopting remote working and conducting decentralised clinical trials. Before investing in new technology, companies must incorporate emerging technologies based on their business needs and create a solid digital transformation plan. According to Statista - As of May 7, 2021, there were 1,177 drugs and vaccines in development targeting the coronavirus disease (COVID-19). American company ImmunoPrecise Antibodies and UK-based GlaxoSmithKline were ranked second among companies worldwide each with nine drugs/vaccines in development targeting COVID-19. GlobalData provides us information about technologies like cloud computing and cybersecurity have aided the industry in adopting remote working and conducting decentralised clinical trials. Before investing in new technology, companies must incorporate emerging technologies based on their business needs and create a solid digital transformation plan. Some have donated compounds that could treat coronavirus for emergency use and clinical trials, including those that were previously tested on other viral pathogens including Ebola and HIV. Others are looking at how they can use existing technology to quickly scale up development once a vaccine candidate has been found. Pharmaceutical firms have a wealth of scientific expertise gleaned from decades Dynamics of Pharmaceutical Companies in the Covid-19 PANDEMIC Current Global Industry Scenario 21 | JULY 2021 | www.insightssuccess.in
  17. 17. of dealing with viruses of a similar nature. Companies are looking at vaccine candidates and conducting inventories of research portfolio libraries in order to find new R&D therapies. There are various pharmaceutical companies in the world that are treating and developing the vaccine which are: • AbbVie: AbbVie is a member of the COVID R&D Alliance and the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) collaboration. Both partnerships are looking at Abbvie medicines. They are also working on antibody discovery and have formed a research partnership with Harvard University to study and create novel therapies for emerging viral infections. • Boehringer Ingelheim In close collaboration with academic researchers, foreign institutions, and others in the pharmaceutical industry, Boehringer Ingelheim quickly established the areas of expertise where they would better contribute to developing COVID-19 therapies. • Johnson & Johnson: Johnson & Johnson is a renowned pharmaceutical company. J&J is working to classify current or new compounds with antiviral activity against COVID-19 in collaboration with the Rega Institute for Medical Research at the University of Leuven (Belgium). • Pfizer: Pfizer is testing an antiviral compound – a so-called "protease inhibitor" discovered by Pfizer scientists in 2003, as a COVID-19 drug. The capacity of the virus to replicate is disrupted by this possible therapy. Pfizer also laid out a concise five-point strategy to combat COVID-19. The initiative includes a pledge to share its drug development and regulatory experience with other smaller biotech companies looking to test compounds or existing therapies for action against the virus that causes COVID-19. • Takeda: The CoVIg-19 Plasma Alliance, which includes Takeda and several other firms, is currently performing a phase 3 trial of an anti-coronavirus immunoglobulin (ITAC). The trial will look at the protection, tolerability, and efficacy of an investigational anti-coronavirus hyperimmune intravenous immunoglobulin (H-Ig) medicine for treating COVID-19 disease in hospitalised adults. • AstraZeneca: AstraZeneca is conducting a Phase 3 trial with the National Institute of Health Research (NIHR) to look at monoclonal antibodies as a treatment for COVID-19. The research is one of two national priority trials focusing on the treatment of two AZD7442 investigational antibodies. • Eli Lilly: Eli Lilly and AbCellera collaborated on the creation of an antibody for the treatment and prevention of COVID-19, which has now been approved by the FDA for the treatment of newly diagnosed COVID-19. • GSK: GSK is a member of the COVID-19 Therapeutics Accelerator, a joint research initiative. They're still working with Vir Biotechnology to create new dual-action monoclonal antibodies, and they are looking at their own marketed pharmaceuticals and drugs in progress to see whether any of them may be used in the pandemic. • MSD: MSD is advancing the production and manufacturing of two investigational therapeutics: a novel immune modulator candidate and a novel antiviral candidate developed in partnership with Ridgeback Bio. • Novartis: Novartis is a participant in the COVID-19 Therapeutics Accelerator, a joint research project led by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard, as well as a COVID-19-focused collaboration organised by the Innovative Medicines Initiative. • Roche: In the case of COVID-19, Roche is looking at its current portfolio. It has announced the start of many clinical trials and is also gathering and compiling data from other, independently led clinical trials around the world, as well as collaborating with other companies and research organisations. -Ashish Chandgude 22 | JULY 2021 | www.insightssuccess.in

×